Myron Brown, in Ellendale, DE - Psychologist

Myron Brown, is a Psychologist - Intellectual & Developmental Disabilities based in Ellendale, Delaware. Myron Brown is licensed to practice in Delaware (license number ) and his current practice location is 17133 Ellendale Forest Rd., Ellendale, Delaware. He can be reached at his office (for appointments etc.) via phone at (302) 573-1231.

NPI number for Myron Brown is 1417554759 and his current mailing address is 17133 Ellendale Forest Rd., Ellendale, Delaware. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1417554759.

Contact Information

	Myron Brown,
	17133 Ellendale Forest Rd., Ellendale, DE 19941-3226
	(302) 573-1231
	Not Available

Healthcare Provider's Profile

Full Name	Myron Brown
Gender	Male
Speciality	Psychologist - Intellectual & Developmental Disabilities
Location	17133 Ellendale Forest Rd., Ellendale, Delaware
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1417554759
Provider Enumeration Date: 10/08/2020
Last Update Date: 10/08/2020

Medical Identifiers

Medical identifiers for Myron Brown such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417554759	NPI	-	NPPES
250557951	Medicaid	DE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TM1800X	Psychologist - Intellectual & Developmental Disabilities	(Delaware)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Myron Brown is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Myron Brown, 17133 Ellendale Forest Rd., Ellendale, DE 19941-3226 Ph: () -	Myron Brown, 17133 Ellendale Forest Rd., Ellendale, DE 19941-3226 Ph: (302) 573-1231

News Archive

Many countries lack important legal child labor protections, UCLA study finds

Despite international commitments made by nearly all of the 193 United Nations member states, dozens of countries lack important legal protections against children doing work that could be harmful or interfere with their education, a study by the WORLD Policy Analysis Center at the UCLA Fielding School of Public Health has found.

New outpatient imaging center opened in Waukesha's Westbrook Health Center

Center for Diagnostic Imaging (CDI) has opened a new outpatient imaging center in Waukesha's Westbrook Health Center, and has relocated all of its Delafield center services to this new location. The new center allows CDI to expand services to include high-field (1.5T) MRI, multi-slice CT as well as x-ray. In addition, there are plans of offering digital mammography and ultrasound services in early 2010.

Alternative food networks connect ethical producers and consumers and can lead to healthier eating

In the light of growing concerns about the separation of producers and consumers in our food system and the power of big supermarkets, new research funded by Economic and Social Research Council (ESRC) provides valuable insights into the motivations and practices of consumers and producers involved in ‘alternative food' networks, which include schemes as varied as organic vegetable boxes, community gardens and farm animal adoption.

Proteomics yields new drug targets for treating cardiogenic shock

When it comes to cell signaling and bioregulation, it's tough to find a more important molecule than nitric oxide (NO). Dysfunction of NO-mediated signaling is thought to be a culprit in lethal cardiovascular conditions such as angina, and septic, cardiogenic and hemorrhagic shock; it may play a role in many other illnesses as well.

Drug could be repurposed to help end transplant rejection

A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs, according to new research by Queen Mary University of London.

Myron Brown, - Psychologist in Ellendale, DE